TNAG-1710-FCO40-2386-Royal-visits-from-the-UK-to-Hong-Kong-1987 — Page 53

(c) Notify, as soon as possible, the competent national authorities and services of the Parties concerned if there is reason to believe that the import, export or transit of a substance in List A or in List B is destined for the illicit processing or manufacture of narcotic drugs or psychotropic substances, including in particular information on the means of payment and on any other essential elements which led to that belief.

(d) Require that imports and exports be properly labelled and documented. Commercial documents such as invoices, cargo manifests, bills of lading, customs documents and other shipping documents shall include the names as stated in List A or in List B of the substances being imported or exported, the quantity being imported or exported, and the name and address of the importer, the exporter and [, when available,] the consignee.

(e)

Ensure that documents referred to in subparagraph (d) are maintained for a period of not less than two years and may be made available for inspection by the competent national authorities

(a) In addition to the provisions of paragraph 9, each Party from whose territory a substance in List A is to be exported shall ensure that, prior to such export, the following information is supplied by its competent authorities to the competent authorities of the importing country:

(i) The name and address of the exporter and importer;

11.

(ii)

The designation of the substance in List A;

The quantity of the substance exported;

(iii)

(iv)

The presumed point of entry and estimated date of despatch.

(b) A Party may adopt more strict or severe measures of control than those provided by this paragraph if, in its opinion, such measures are desirable or necessary.

Each Party shall furnish annually to the Board, in the form and manner provided for by it and on forms made available by it, information on:

12.

(a) The amounts seized of substances in List A and in List B, and, when known, their origin;

(b) Any substance not included in List A or List B which is identified as having been used in illicit processing or manufacture of narcotic drugs or psychotropic substances, and which is deemed by the Party to be sufficiently significant to be brought to the attention of the Board;

(c) Methods of diversion and illicit processing or manufacture.

The Board shall report annually to the Commission on the implementation of this article and the Commission shall periodically review the adequacy and propriety of Lists A and B.